Press Release: GYANT Appoints Dr. Justin Graham Chief Medical Officer
Experienced digital health executive, innovator and clinician brings proven expertise improving patient outcomes and driving efficiencies
October 22, 2020
SAN FRANCISCO–(BUSINESS WIRE)–GYANT, the AI-powered virtual assistant company, today announced that Justin Graham, MD, MS, has joined the company as Chief Medical Officer (CMO). Dr. Graham is a seasoned digital health executive and clinical practitioner who brings to GYANT more than 25 years of experience in medicine, infectious disease, informatics, electronic health records, and healthcare operations.
In his new role, Dr. Graham will be responsible for providing medical and clinical leadership for GYANT’s product strategy, owning development and maintenance of all clinical content and protocols, including clinical application of AI. Dr. Graham will continuously evaluate outcomes and risk to ensure efficacy and safety of GYANT’s products.
“Dr. Graham joins GYANT at the perfect intersection of innovation and opportunity within digital health, particularly with regard to virtually guiding patients through increasingly complex healthcare systems,” said Stefan Behrens, co-founder and CEO of GYANT. “His depth of experience with real world care delivery and passion for optimizing the digital patient experience will add incredible value to product innovation and aligns perfectly with our customers’ approach to engaging and treating patients, improving workflows, and reducing costs.”
“I am excited to join a company that’s pushing the limits on virtual care navigation and delivery,” said Graham. “As both a clinician and executive during the digital health revolution, I’ve had substantial experience implementing digital tools to make meaningful impacts on patient experience, internal workflows, and delivery of care. GYANT has all of the ingredients of a company that is perfectly-positioned to lead the next wave of transformation in empowering patients to take control of their digital journeys.”
Dr. Graham joins GYANT as the team continues helping health systems fight the COVID-19 pandemic. Following GYANT’s great success with its COVID-19 SERA tool and having recently announced GYANT Vaccine in anticipation of a pending COVID-19 vaccine deployment, Dr. Graham’s expertise in infectious disease and healthcare operations will be instrumental in keeping one step ahead of healthcare’s most pressing needs.
For more information on GYANT’s innovative technology, visit https://gyant.com/.
GYANT’s empathetic, intuitive virtual assistant guides patients through the complexity of their healthcare systems. With dozens of clients throughout the United States, GYANT partners with Integrated Delivery Networks to deploy its technology on their websites, mobile apps, and patient portals, empowering patients to take control and connect the dots across their digital journeys and more meaningfully engage with their providers any time of the day, every day of the year. GYANT reduces clinical strain and support staff overhead, improves outcomes, and exceeds patient expectations. GYANT’s conversational AI handholds patients from the virtual front door through their entire clinical journey by integrating deeply into clinical workflows (EHRs). The result is a higher level of efficiency that improves patient outcomes and makes them feel truly valued, now and every time they return. Some of GYANT’s customers include Intermountain Healthcare, OSF HealthCare, Adventist Health, Cleveland Clinic, and Geisinger. https://gyant.com/